Diabetes Research and Clinical Practice
Volume 74, Issue 2 , Pages 154-161 , November 2006

Association between impaired glucose metabolism and quality of life: Results from the Australian diabetes obesity and lifestyle study

  • Robyn J. Tapp

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • International Diabetes Institute, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Epidemiology & Preventive Medicine, Central & Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Vic. 3004, Australia.
  • ,
  • David W. Dunstan

      Affiliations

    • International Diabetes Institute, Melbourne, Australia
  • ,
  • Pat Phillips

      Affiliations

    • Endocrinology Unit, Queen Elizabeth Hospital, Adelaide, South Australia
  • ,
  • Andrew Tonkin

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
  • ,
  • Paul Z. Zimmet

      Affiliations

    • International Diabetes Institute, Melbourne, Australia
  • ,
  • Jonathan E. Shaw

      Affiliations

    • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    • International Diabetes Institute, Melbourne, Australia
  • ,
  • on behalf of the AusDiab study group

Received 28 November 2005 ,Accepted 15 March 2006.

References 

  1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787
  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  3. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–932
  4. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396–1402
  5. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26:2300–2304
  6. Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care. 2002;25:476–481
  7. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004;27:1066–1070
  8. Manuel DG, Schultz SE. Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care. 2004;27:407–414
  9. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238–2243
  10. Commonwealth of Australia. National Diabetes Strategy. Canberra: Commonwealth Department of Health and Aged Care; 1999;pp. 1–16
  11. UKPDS . Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125–1136
  12. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25:458–463
  13. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001;4:392–400
  14. De Rekeneire N, Resnick HE, Schwartz AV, Shorr RI, Kuller LH, Simonsick EM, et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the health, aging, and body composition study. Diabetes Care. 2003;26:3257–3263
  15. Dunlop DD, Manheim LM, Sohn MW, Liu X, Chang RW. Incidence of functional limitation in older adults: the impact of gender, race, and chronic conditions. Arch. Phys. Med. Rehabil. 2002;83:964–971
  16. Dunstan D, Zimmet P, Welborn T, Cameron A, Shaw J, deCourten M, et al. AusDiab Steering Committee: the australian diabetes obesity and lifestyle study (AusDiab)-methods and response rates. Diabetes Res. Clin. Pract. 2002;57:119–129
  17. World Health Organisation . Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1. Diagnosis and Classification of Diabetes Mellitus.. Geneva: Department of Noncommunicable Disease Surveillance; 1999;
  18. Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: a Users Manual. Boston, MA: The Health Institute; 1994;
  19. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: EURODIAB IDDM complications study. Diabetologia. 1995;38:437–444
  20. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154
  21. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care. 1997;20:1273–1278
  22. Ewing DJ, Clarke BF. Diagnosis and managment of diabetic autonomic neuropathy. Br. Med. J. 1982;285:916–918
  23. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 1991;20:384–392
  24. Leng GC, Fowkes FG. The Edinburgh claudication questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J. Clin. Epidemiol. 1992;45:1101–1109
  25. Hiltunen L, Keinanen-Kiukaanniemi S. Does glucose tolerance affect quality of life in an elderly population?. Diabetes Res. Clin. Pract. 1999;46:161–167
  26. He XZ, Baker DW. Body mass index, physical activity, and the risk of decline in overall health and physical functioning in late middle age. Am. J. Public Health. 2004;94:1567–1573
  27. Brown DW, Balluz LS, Heath GW, Moriarty DG, Ford ES, Giles WH, et al. Associations between recommended levels of physical activity and health-related quality of life. Findings from the 2001 Behavioral Risk Factor Surveillance System (BRFSS) survey. Prev. Med. 2003;37:520–528
  28. Haveman-Nies A, de Groot LC, van Staveren WA. Dietary quality, lifestyle factors and healthy ageing in Europe: the SENECA study. Age Ageing. 2003;32:427–434
  29. Johansson SE, Sundquist J. Change in lifestyle factors and their influence on health status and all-cause mortality. Int. J. Epidemiol. 1999;28:1073–1080
  30. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1991;325:147–152
  31. Arnold R, Ranchor AV, Sanderman R, Kempen GI, Ormel J, Suurmeijer TP. The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual. Life Res. 2004;13:883–896
  32. Nichols GA, Brown JB. Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care. 2003;26:744–749
  33. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20:562–567
  34. Woodcock AJ, Julious SA, Kinmonth AL, Campbell MJ, Caruso LB, Silliman RA, et al. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. J. Gerontol. A: Biol. Sci. Med. Sci. 2000;661–670

PII: S0168-8227(06)00113-6

doi: 10.1016/j.diabres.2006.03.012

Diabetes Research and Clinical Practice
Volume 74, Issue 2 , Pages 154-161 , November 2006